tiprankstipranks
Santen Pharmaceutical Co Ltd (JP:4536)
:4536
Japanese Market
4536
Santen Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4536 full AI Analyst Report?

Santen Pharmaceutical Co (4536) Financial Statements

0 Followers

Santen Pharmaceutical Co Financial Overview

Santen Pharmaceutical Co's market cap is currently ¥612.35B. The company's EPS TTM is ¥114.03; its P/E ratio is 15.65; and it has a dividend yield of 2.30%. Santen Pharmaceutical Co is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ¥20.50. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 26Mar 25Mar 24Mar 23
Income Statement
Total Revenue¥ 300.00B¥ 291.62B¥ 301.96B¥ 279.04B¥ 266.26B
Gross Profit¥ 163.21B¥ 160.97B¥ 163.88B¥ 156.57B¥ 146.85B
Operating Income¥ 56.23B¥ 45.22B¥ 51.90B¥ 32.02B¥ 35.98B
EBITDA¥ 74.18B¥ 63.57B¥ 70.08B¥ 49.26B¥ 53.03B
Net Income¥ 36.26B¥ 37.37B¥ 26.64B¥ -14.95B¥ 27.22B
Balance Sheet
Cash & Short-Term Investments¥ 93.00B¥ 80.88B¥ 94.58B¥ 57.90B¥ 83.01B
Total Assets¥ 409.28B¥ 423.03B¥ 435.70B¥ 421.18B¥ 459.98B
Total Debt¥ 33.95B¥ 0.00¥ 35.16B¥ 35.96B¥ 22.00B
Net Debt¥ -59.04B¥ -80.88B¥ -59.42B¥ -21.94B¥ -61.02B
Total Liabilities¥ 124.10B¥ 127.02B¥ 130.33B¥ 127.88B¥ 123.13B
Stockholders' Equity¥ 286.24B¥ 296.99B¥ 306.05B¥ 293.98B¥ 337.49B
Cash Flow
Free Cash Flow¥ 54.27B¥ 36.66B¥ 63.33B¥ 19.87B¥ 28.70B
Operating Cash Flow¥ 60.93B¥ 43.50B¥ 72.65B¥ 37.15B¥ 46.04B
Investing Cash Flow¥ -8.22B¥ -12.97B¥ -6.14B¥ -26.78B¥ -35.17B
Financing Cash Flow¥ -53.31B¥ -49.35B¥ -34.03B¥ -37.22B¥ 5.56B
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History

Income Statement >

Santen Pharmaceutical Co Debt to Assets

Balance Sheet >

Santen Pharmaceutical Co Cash Flow

Cash Flow >

Santen Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >